Chronic nerve pain can be extremely difficult to live with. For millions of people, the pain can last for years and interfere with daily activities such as walking, sleeping, or even sitting comfortably.
This type of pain is known as neuropathic pain. It happens when nerves become damaged or stop working properly, sending pain signals to the brain even when there is no clear injury.
In the United States alone, more than 20 million people live with neuropathic pain. One common form of this condition is called cryptogenic sensory polyneuropathy, often shortened to CSPN. In this disorder, patients experience nerve pain, numbness, burning sensations, or tingling in their hands or feet.
The word “cryptogenic” means that doctors do not know the exact cause of the condition. Because the cause is unknown, treating the pain can be especially challenging.
Doctors often try different medications to help control nerve pain, but there has been limited research comparing which medicines work best for people with CSPN. Without strong evidence, physicians sometimes have to rely on trial and error, prescribing one drug and then switching to another if the first does not work or causes side effects.
To better understand which treatments may be most helpful, researchers from the University of Missouri carried out a large clinical study comparing several commonly used medications for nerve pain. Their goal was to find out which drugs provide the best balance between reducing pain and being easy for patients to tolerate.
The study included 402 adults aged 30 years or older who had been diagnosed with cryptogenic sensory polyneuropathy. All of the participants reported moderate to severe nerve pain.
To measure this, researchers used a standard pain scale from 0 to 10, where higher numbers represent stronger pain. Every participant reported a pain level of four or higher at the start of the study.
The participants were randomly assigned to take one of four medications for a period of twelve weeks. Random assignment is important in clinical research because it helps make sure the results are fair and not influenced by outside factors.
The four medications tested in the study were nortriptyline, duloxetine, pregabalin, and mexiletine. Each of these drugs is already used in medicine for different purposes. Nortriptyline is a type of antidepressant known as a tricyclic antidepressant, but it has also been used for many years to treat nerve pain.
Duloxetine is another antidepressant that affects certain brain chemicals related to pain and mood. Pregabalin is a medication originally developed to treat seizures, and it is also used to treat nerve-related pain conditions. Mexiletine is typically used to treat irregular heart rhythms, although it has sometimes been prescribed for nerve pain as well.
During the study, researchers checked on the participants after four weeks, eight weeks, and twelve weeks. They looked at two main things. First, they measured how well each medication reduced the patients’ pain.
Second, they examined how many patients stopped taking the medication because of side effects or other problems. This “dropout rate” helps researchers understand how tolerable a treatment is in real life.
When the results were analyzed, nortriptyline showed the best overall balance between effectiveness and tolerability. About 25 percent of the patients taking nortriptyline experienced meaningful pain relief. In addition, the dropout rate for this drug was relatively moderate, with about 38 percent of patients stopping the medication.
Duloxetine also performed well in the study. It had a slightly lower pain relief rate, helping about 23 percent of patients, but it had the lowest dropout rate among the four medications at 37 percent. This means that patients were somewhat more likely to continue taking duloxetine without stopping due to side effects.
Pregabalin was less successful in this study. Only about 15 percent of patients taking pregabalin reported significant improvement in their pain levels. Meanwhile, mexiletine performed the worst overall. It had the highest dropout rate, with about 58 percent of patients stopping the medication, suggesting that many people found it difficult to tolerate.
Although the study did not identify a single drug that works best for every patient, the findings suggest that nortriptyline and duloxetine may be good first options for many people with cryptogenic sensory polyneuropathy. These medications appear to provide a reasonable level of pain relief while remaining tolerable for a larger number of patients.
The researchers also noted that other medications are sometimes used for neuropathic pain, including gabapentin, venlafaxine, and drugs that affect sodium channels in nerve cells. Future studies may compare these treatments as well to give doctors clearer guidance when treating this difficult condition.
For patients living with CSPN, chronic nerve pain can be frustrating and exhausting, especially when the cause of the condition remains unknown. Research like this helps doctors make more informed decisions and offers hope that better treatment strategies will continue to emerge.
The study was led by neurologist Richard Barohn from the University of Missouri and was published in the medical journal JAMA Neurology. By comparing several commonly used medications in a large group of patients, the research provides valuable insight into how doctors may better manage this challenging form of neuropathic pain.
If you care about pain, please read studies about vitamin K deficiency linked to hip fractures in old people, and these vitamins could help reduce bone fracture risk.
For more health information, please see recent studies that Krill oil could improve muscle health in older people, and eating yogurt linked to lower frailty in older people.
Copyright © 2026 Knowridge Science Report. All rights reserved.
